GlassScriptPhysician profile
John Douglas Mccarter
NPI 1679761365
$1,240.44
in general payments reported to CMS, 2019-2025
25 companies · $367 in 2025
The $367 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $93.11 · 2021: $171 · 2022: $289 · 2023: $55.89 · 2024: $105 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $527.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $150.90 | 2019-2025 | Myosure Tissue Removal Device |
| Exeltis, USA INC. | $147.95 | 2020-2025 | Slynd |
| Biogen, INC. | $144.70 | 2024-2025 | Zurzuvae |
| Organon LLC | $137.01 | 2022-2025 | Nexplanon |
| Channel Medsystems, INC. | $110.89 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.88 | 2019-2023 | |
| Avanos Medical | $60.83 | 2019 | |
| Daiichi Sankyo INC. | $43.60 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $41.67 | 2019-2020 | |
| Valencia Technologies Corporation | $40.53 | 2025 | Ecoin Device Kit |
| Shield Therapeutics INC | $35.33 | 2025 | |
| Mayne Pharma Commercial LLC | $34.82 | 2022-2023 | |
| Abbvie INC. | $31.12 | 2021 | |
| Solventum Corporation | $26.03 | 2025 | Prevena, Activ.A.C. |
| Mission Pharmacal Company | $25.64 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $22.60 | 2019-2020 | |
| Meditrina | $14.19 | 2025 | |
| Dysis Medical, INC. | $14.02 | 2021 | |
| Pfizer INC. | $13.93 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $13.86 | 2025 | |
| Innovation Technologies INC | $13.83 | 2025 | Irrisept |
| Lilly USA, LLC | $13.75 | 2025 | Mounjaro, Zepbound |
| Ethicon US, LLC | $13.32 | 2022 | |
| Allergan, INC. | $13.07 | 2020 | |
| Sage Therapeutics, LLC | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mccarter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.